Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil

J Natl Cancer Inst. 1989 May 3;81(9):706-9. doi: 10.1093/jnci/81.9.706.

Abstract

In a set of four increasingly multidrug-resistant variants of SW-1573 human lung tumor cells, the pHi (i.e., steady-state cytosolic pH) increased up to 0.44 U as a function of the level of doxorubicin resistance. The elevated pHi in the most resistant (2,000-fold) variant dropped to the control level upon addition of verapamil, a known inhibitor of P-glycoprotein activity. These data suggest that, in the absence of xenobiotic substrates, P-glycoprotein activity can affect cellular pHi. This finding may be important for the elucidation of the physiological function of this protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins / analysis
  • Cytosol / metabolism
  • Doxorubicin / pharmacology
  • Drug Resistance
  • Humans
  • Hydrogen-Ion Concentration
  • Lung Neoplasms / pathology
  • Membrane Glycoproteins / analysis*
  • Sodium-Hydrogen Exchangers
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Cells, Cultured
  • Verapamil / pharmacology*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins
  • Membrane Glycoproteins
  • Sodium-Hydrogen Exchangers
  • Doxorubicin
  • Verapamil
  • Tetradecanoylphorbol Acetate